- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01315028
Bipolar Intervention Study: Cognitive Interpersonal Therapy (BISCIT)
A Pilot Randomised Controlled Trial of Cognitive Behaviour Therapy for Early Bipolar Disorder
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The 'PICO' framework (Oxman, Sackett, and Guyatt, 1993; Richardson, Wilson, Nishikawa, and Hayward; 1995) was used to specify the parameters of the study aims and objectives:
- Population: could appropriate individuals be identified and recruited to a trial of CIT for early bipolar disorder?
- Intervention: would CIT be an acceptable intervention for individuals following a first or second treated episode of mania and or hypomania? Could we identify any modifications required to the CIT protocol used with this group?
- Control group: could an appropriate group of participants be recruited to facilitate a comparison with the CIT intervention? Could we explicitly establish the usual care package and its local implementation?
- Outcomes: which outcomes are appropriate for measuring relevant dimensions of a treatment effect?
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Glasgow, United Kingdom
- NHS Greater Glasgow & Clyde
-
-
Lanarkshire
-
Glasgow, Lanarkshire, United Kingdom, G12 0XH
- Gartnavel Royal Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Eligible individuals will have experienced their first or second treated episode of mania and / or hypomania in the previous 12-months prior to study entry.
Exclusion Criteria:
- Participants will be excluded if there is a (1) diagnosis of learning disability; (2) inability to participate in psychotherapy/research due to acute medical condition or acute mania
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Psychological Therapy
Cognitive Interpersonal Therapy (CIT) was a psychological therapy which emphasised assessment, engagement and formulation; normalizing and compassionate understanding; specific cognitive-behavioural and interpersonal strategies; self-management and social rhythm regulation; affect regulation, and staying well (Gumley & Schwannauer, 2006).
|
Cognitive Interpersonal Therapy in Early Bipolar Disorder: Individuals will receive up to six months of individual CIT-BP.
CBT will emphasise assessment, engagement and formulation; normalizing and compassionate understanding; specific cognitive and behavioural strategies; self-management and social rhythm regulation; affect regulation, and staying well (Gumley & Schwannauer, 2006).
Other Names:
|
|
Active Comparator: Treatment As Usual
All participants continued to receive their usual care from their local community mental health team and other psychological therapies were not withheld during the conduct of the trial.
|
The comparison group is treatment as usual (TAU).
This will comprise of the individuals normal psychiatric care and will vary with individual and locality and is therefore not specified.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Montgomery Asberg Depression Rating Scale (MADRS) (Montogomery and Asberg, 1979)
Time Frame: Baseline to End of Study.
|
The Montgomery Asberg Depression Rating Scale (MADRS) (Montgomery and Asberg, 1979) is a semi-structured interview designed to assess the presence and severity of 10 core symptoms of depression. Higher MADRS score indicates more severe depression, and each item yields a score of 0 to 6. The overall score ranges from 0 to 60. The questionnaire includes questions on the following symptoms 1. Apparent sadness 2. Reported sadness 3. Inner tension 4. Reduced sleep 5. Reduced appetite 6. Concentration difficulties 7. Lassitude 8. Inability to feel 9. Pessimistic thoughts 10. Suicidal thoughts. Usual cutoff points are: 0 to 6 - normal /symptom absent 7 to 19 - mild depression 20 to 34 - moderate depression >34 - severe depression |
Baseline to End of Study.
|
|
Bech-Rafaelsen Mania Rating Scale (BRMS) [Bech et al, 1979]
Time Frame: Baseline to End of Study
|
The Bech-Rafaelsen Mania Rating Scale (BRMS) [Bech et al, 1979] provides a structured format for a clinician to assess the presence and severity of 11 core symptoms of hypomania or mania.Higher BRMS score indicates more severe symptoms of mania, and each item yields a score of 0 to 4. The overall score ranges from 0 to 44. Usual cutoff points are: 0 to 15 - normal /symptom absent 15 to 20 - mild 21 to 28 - moderate >34 - severe |
Baseline to End of Study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Internal State Scale (ISS) (Bauer et al, 1991)
Time Frame: monthly until October 2011
|
The Internal State Scale (ISS) (Bauer et al, 1991) is a 15 item self-report scale that utilizes 100 mm visual analogue scales to assess the presence and severity of symptoms, ranging from 'not at all / rarely' to 'very much so / much of the time' (score range per item 0 to 100). The ISS assesses depressive and hypomanic / manic symptoms across four factors: perceived conflict, activation, well-being and depression. Perceived Conflict is assessed across 5 items (score range 0 to 500), Activation across 5 items (score range 0 to 500), Well-being across 3 items (score range 0 to 300) and Depression across 2 items (score range 0 to 200). The Well-being subscale is used in conjunction with the Activation subscale for mood state discrimination. The suggested scoring algorithm is as follows: Mood State Activation Subscale Score Well-Being Subscale Score (Hypo)Mania >155 >125 Mixed State >155 <125 Euthymia <155 >125 Depression <155 |
monthly until October 2011
|
|
Global Assessment of Functioning (GAF)
Time Frame: monthly until October 2011
|
Participant functioning was assessed using the Global Assessment of Functioning (GAF) (APA, 1987).
The Global Assessment of Functioning (GAF) is a numeric scale (0 through 100) used by mental health clinicians and physicians to rate subjectively the social, occupational, and psychological functioning of adults, e.g., how well or adaptively one is meeting various problems-in-living, with higher score indicating higher functioning.
The score is often given as a range, from 1 - 10 Persistent danger of severely hurting self or others (e.g., recurrent violence) or persistent inability to maintain minimal personal hygiene or serious suicidal act with clear expectation of death, to 91 - 100 No symptoms.
Superior functioning in a wide range of activities, life's problems never seem to get out of hand, is sought out by others because of his or her many positive qualities.
|
monthly until October 2011
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jamie D Kirk, D.Clin.Psy, NHS Greater Glasgow & Clyde / University of Glasgow
- Study Chair: Andrew I Gumley, PhD, University of Glasgow
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GN09CP546
- CZG/2/472 (Other Grant/Funding Number: Chief Scientist Office, Scottish Executive)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mania
-
Cedars-Sinai Medical CenterNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar Disorder | Mixed Mania | Treatment-Resistant ManiaUnited States
-
Taichung Veterans General HospitalUnknownBipolar, Mania | Utapine | SeroquelTaiwan
-
AstraZenecaTerminated
-
Mclean HospitalWithdrawnBipolar, Mania | Bipolar, Mixed State
-
Bristol-Myers SquibbRecruitingBipolar-I Disorder With Mania or Mania With Mixed FeaturesJapan, United States, Hungary, New Zealand, Bulgaria, Australia, Argentina, Poland
-
Massachusetts General HospitalAbbottCompletedMania | Mixed ManiaUnited States
-
Bristol-Myers SquibbRecruitingBipolar Disorder Type I With Mania or Mania With Mixed FeaturesUnited States, Spain, India, Italy, Romania, Sweden, Israel, Croatia, Slovakia, Ukraine
-
AstraZenecaTerminated
-
Assiut UniversityCompleted
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SCompletedBipolar I Disorder | Acute ManiaUnited States, Serbia, Bulgaria, Croatia, Poland, Ukraine
Clinical Trials on Cognitive Interpersonal Therapy
-
Modum BadCompleted
-
Vanderbilt UniversityCompletedDepressive SymptomsUnited States
-
Centre for Addiction and Mental HealthOntario Mental Health FoundationCompletedMajor DepressionCanada
-
Washington University School of MedicineCompletedBinge Eating Disorder | Cognitive Therapy/Methods | Mental Disorders/Epidemiology | Obesity/Epidemiology | Obesity/TherapyUnited States
-
Linkoeping UniversityVästernorrland County Council, Sweden; REHSAM; Psychiatric clinic, Hospital of...UnknownShort Term Therapy for Outpatients Diagnosed With Major Depressive DisorderSweden
-
Washington University School of MedicineCompletedBinge Eating Disorder | Cognitive Therapy/Methods | Mental Disorders/Epidemiology | Obesity/Epidemiology | Obesity/TherapyUnited States
-
University of PittsburghCarnegie Mellon UniversityCompletedMajor Depressive DisorderUnited States
-
Penn State UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety DisorderUnited States
-
University of California, BerkeleyCompletedEveningness/SleepUnited States
-
Centre for Addiction and Mental HealthOntario Mental Health FoundationCompletedDepression | Major Depressive DisorderCanada